May 29, 2025 Critical Path Institute and Citizen Health Partner to Accelerate Drug Development for Neuromuscular Disorders SAN FRANCISCO and TUCSON, Ariz., May 29, 2025 — Critical Path Institute® (C-Path), a global nonprofit accelerating drug develop
May 27, 2025 C-Path Welcomes Avidity Biosciences as Newest Member to Duchenne Consortium C-Path is excited to welcome Avidity Biosciences as a new member of the Duchenne Regulatory Science Consortium (D-RSC). Avidity is
May 20, 2025 The Critical Path Institute Podcast: eCOA Conversations with Florence Mowlem, Karl McEvoy, and Brian Lillis Welcome to the latest Critical Path Institute Podcast episode—the first in the eCOA Conversations series.
May 12, 2025 C-Path’s Translational Therapeutics Accelerator Awards $815,000 Grant for Drug Development Project in Advanced Prostate Cancer Brisbane-based Queensland Emory Drug Discovery Initiative team awarded funding to advance novel therapy for treatment-resistant pr
May 8, 2025 Critical Path Institute Celebrates 20 Years of Advancing Drug Development through Innovation and Collaboration The year 2025 marks a historic milestone for C-Path as the organization celebrates...
May 6, 2025 C-Path Announces First Data Transfer from Takeda to Accelerate Alpha-1 Innovation TUCSON, Ariz., May 6, 2025 — Critical Path Institute’s® (C-Path) Critical Path for Alpha-1 (CPA-1) consortium is proud to ann
April 25, 2025 C-Path’s CPAD Database Drives Insights into Alzheimer’s Disease C-Path’s Critical Path for Alzheimer’s Disease (CPAD) Consortium is thrilled to share...
April 25, 2025 C-Path’s Stephenson Featured in BioCentury Article C-Path Vice President of Neurology and Executive Director of Critical Path for Parkinson's (CPP) Consortium...
April 14, 2025 C-Path Honors Memory, Legacy of Beloved CP-RND Member and ALS Patient Advocate Layne Oliff Critical Path Institute (C-Path) mourns the loss of one of its ALS community members, Layne Oliff. Layne, who passed on Friday, Ap
April 9, 2025-April 10, 2025 2025 Clinical Outcome Assessment Program Annual Meeting On April 9-10, 2025, the 2025 Clinical Outcome Assessment...
